CA3017975C - Composes de polyglucosamine-arginine, compositions et methodes d'utilisation - Google Patents

Composes de polyglucosamine-arginine, compositions et methodes d'utilisation

Info

Publication number
CA3017975C
CA3017975C CA3017975A CA3017975A CA3017975C CA 3017975 C CA3017975 C CA 3017975C CA 3017975 A CA3017975 A CA 3017975A CA 3017975 A CA3017975 A CA 3017975A CA 3017975 C CA3017975 C CA 3017975C
Authority
CA
Canada
Prior art keywords
paag
molecular weight
weight average
subject
arginine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3017975A
Other languages
English (en)
Other versions
CA3017975A1 (fr
Inventor
Shenda Baker
William P. Wiesmann
Stacy Marie Townsend
Original Assignee
Synedgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synedgen Inc filed Critical Synedgen Inc
Priority claimed from PCT/US2017/022698 external-priority patent/WO2017161113A1/fr
Publication of CA3017975A1 publication Critical patent/CA3017975A1/fr
Application granted granted Critical
Publication of CA3017975C publication Critical patent/CA3017975C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

Il est décrit des méthodes comprenant une quantité efficace de polyglucosamine-arginine (PAAG) de formule (l) et visant à traiter la dysbiose et les maladies ou troubles gastro-intestinaux chez un patient : (voir Formule I).
CA3017975A 2016-03-16 2017-03-16 Composes de polyglucosamine-arginine, compositions et methodes d'utilisation Active CA3017975C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662309281P 2016-03-16 2016-03-16
US62/309,281 2016-03-16
US201662309734P 2016-03-17 2016-03-17
US62/309,734 2016-03-17
PCT/US2017/022698 WO2017161113A1 (fr) 2016-03-16 2017-03-16 Compositions et leurs méthodes d'utilisation

Publications (2)

Publication Number Publication Date
CA3017975A1 CA3017975A1 (fr) 2017-09-21
CA3017975C true CA3017975C (fr) 2025-11-18

Family

ID=

Similar Documents

Publication Publication Date Title
US12533375B2 (en) Compositions and methods of use thereof
Mawad et al. E. coli Nissle microencapsulation in alginate-chitosan nanoparticles and its effect on Campylobacter jejuni in vitro
Liu et al. The role of functional oligosaccharides as prebiotics in ulcerative colitis
AU2010289417B2 (en) Methods and compositions for disrupting biofilm utilizing chitosan-derivative compounds
El-Sayed et al. Microbiota and epigenetics: promising therapeutic approaches?
Ivanovska et al. Synbiotic loaded chitosan-Ca-alginate microparticles reduces inflammation in the TNBS model of rat colitis
CA2743624C (fr) Derives de chitosan pour traiter des animaux ou optimiser la sante animale
O’Doherty et al. Novel marine polysaccharides and maternal nutrition to stimulate gut health and performance in post-weaned pigs
EP3359126B1 (fr) Oligomères d'alginate destinés au traitement ou à la prévention d'une croissance microbienne excessive dans le tractus intestinal
US20230021050A1 (en) Compositions and methods of their use
Gassull The intestinal lumen as a therapeutic target in inflammatory bowel disease
Liu et al. Chitosan modulates inflammatory responses in rats infected with enterotoxigenic Escherichia coli
CA3017975C (fr) Composes de polyglucosamine-arginine, compositions et methodes d'utilisation
Ghasemi-Niri et al. On the benefit of whey-cultured Lactobacillus casei in murine colitis
Yong et al. Chitosan for Body Weight Management
Gionchetti et al. Probiotics, prebiotics, and antibiotics in IBD
US11491192B2 (en) Treatment and prevention of pathogenic bacterial overgrowth using butyrate-producing bacteria
AU2015255317B2 (en) Methods and Compositions for Disrupting Biofilm Utilizing Chitosan-Derivative Compounds
Calafiore et al. Gastroenterology and Hepatology Research
AU2020277272A1 (en) Methods and compositions for disrupting biofilm utilizing chitosan-derivative compounds
Prisciandaro et al. Probiotics and prebiotics in inflammatory bowel disease
Gionchetti et al. Probiotics, Prebiotics, and Antibiotics in Medical Management of Inflammatory Bowel Disease